25-06-2020

                                                          COVID-19 DRUG UPDATES

Now, a COVID-19 drug is just formed by Hyderabad drugmaker Hetero, and get approved to launch their vaccines in some very risky states.




Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.

Gujarat and Tamil Nadu are the other two states that will receive the first batch of the drug which is being marketed under the brand name COVIFOR in India. Telangana's capital Hyderabad, where the drugmaker is based, will also receive the first consignment.

Hetero said a 100-milligram vial of the drug will cost Rs 5,400. The recommended dose for adults and pediatric patients is 200 mg on Day 1 followed by once daily maintenance doses of 100 mg for five days.

The next batch of the drug will be shipped to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Kochi, Trivandrum and Goa.

"Remdesivir is an antiviral that was used for the treatment of Ebola and has been repurposed for treatment of Covid-19. Part of the Word Health Organisation’s ongoing Solidarity Trials, Remdesivir received emergency use authorisation by the United States Food and Drug Administration (USFDA) on May 1"

On June 21, the Central Drugs Standard Control Organisation gave approval to Hetero Drugs and Cipla to manufacture and market remdesivir. Both the firms have already entered into non-exclusive licensing agreements with Gilead Sciences, which is the patent holder of the drug remdesivir.

Hetero has said the drug, named Covifor, will be available in 100 mg vials (injectable), which has to be administered intravenously in a hospital setting. Hetero Group of Companies MD Vamsi Krishna Bandi told PTI the price of its remdesivir will be in the range of Rs 5,000-6,000 per dose.







                                                                                     THANKYOU🙏🙏🙏......

Comments

Popular posts from this blog

Python Language Part-1

Python Language Part-2

Top Headlines.......... (20/09/2020)